Infection-Related Focal Segmental Glomerulosclerosis in Children

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Dettmar, Anne Katrin ^a   Oh, Jun ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; AUTOPHAGY; CELL DEATH; CELL PROLIFERATION; CHILDHOOD DISEASE; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FOCAL GLOMERULOSCLEROSIS; GRAFT SURVIVAL; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PARVOVIRUS B19; IN VITRO STUDY; NEPHROLOGIST; NONHUMAN; PATHOGENESIS; PODOCYTE; REVIEW; VIRUS INFECTION; ANIMAL; CHILD; COMPLICATION; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; VIROLOGY;

ANIMALS; CHILD; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; PODOCYTES; VIRUS DISEASES;

EID: 84973345443     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/7351964     Document Type: Review

References (91)

1. J. A. Jefferson and S. J. Shankland, "The pathogenesis of focal segmental glomerulosclerosis," Advances in Chronic Kidney Disease, vol. 21, no. 5, pp. 408-416, 2014.
2. M. Vinai, P. Waber, M. G. Seikaly, "Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review," Pediatric Transplantation, vol. 14, no. 3, pp. 314-325, 2010.
3. A. B. Fogo, "Causes and pathogenesis of focal segmental glomerulosclerosis," Nature Reviews Nephrology, vol. 11,no. 2, pp. 76-87, 2015.
4. H. Yu, M. Artomov, S. Brähler et al., "A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis," The Journal of Clinical Investigation, vol. 126, no. 3, pp. 1067-1078, 2016.
5. P. Chandra and J. B. Kopp, "Viruses and collapsing glomerulopathy: a brief critical review," Clinical Kidney Journal, vol. 6, no. 1, pp. 1-5, 2013.
6. A. S. H. Lai and K. N. Lai, "Viral nephropathy," Nature Clinical Practice Nephrology, vol. 2, no. 5, pp. 254-262, 2006.
7. R. J. Glassock, "Immune complex-induced glomerular injury in viral diseases: an overview," Kidney International, vol. 40,no. 35, pp. S5-S7, 1991.
8. W. G. Couser, "Mechanisms of glomerular injury in immunecomplex disease," Kidney International, vol. 28, no. 3, pp. 569-583, 1985.
9. P. G. Conaldi, L. Biancone, A. Bottelli et al., "HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation,"The Journal of Clinical Investigation, vol. 102, no. 12, pp. 2041-2049, 1998.
10. S. Segerer, P. J. Nelson, D. Schlöndorff, "Chemokines, chemokine receptors, renal disease: from basic science to pathophysiologic and therapeutic studies," Journal of the American Society of Nephrology, vol. 11, no. 1, pp. 152-176, 2000.
11. J. Zhong, Y. Zuo, J. Ma et al., "Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy," Kidney International, vol. 68, no. 3, pp. 1048-1060, 2005.
12. S. E. Wenderfer, "Viral-associated glomerulopathies in children," Pediatric Nephrology, vol. 30, no. 11, pp. 1929-1938, 2015.
13. UNAIDS, World AIDS Day Report, 2011, http://www. unaids . org/sites/default/files/media asset/JC2216 WorldAIDSday report 2011 en 0. pdf, http://www. unaids. org/sites/default/files/en/media/unaids/contentassets/documents/factsheet/2011/20111121 FS WAD2011 global en. pdf.
14. M.-L. Newell, H. Coovadia, M. Cortina-Borja, N. Rollins, P. Gaillard, F. Dabis, "Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis," The Lancet, vol. 364, no. 9441, pp. 1236-1243, 2004.
15. P. L. Kimmel, T. M. Phillips, A. Ferreira-Centeno, T. Farkas-Szallasi, A. A. Abraham, C. T. Garrett, "HIV-associated immune-mediated renal disease," Kidney International, vol. 44, no. 6, pp. 1327-1340, 1993.
16. V. Shahinian, S. Rajaraman, M. Borucki, J. Grady, W. M. Hollander, T. S. Ahuja, "Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients," American Journal of Kidney Diseases, vol. 35, no. 5, pp. 884-888, 2000.
17. E. Daugas, J.-P. Rougier, G. Hill, "HAART-related nephropathies in HIV-infected patients," Kidney International, vol. 67, no. 2, pp. 393-403, 2005.
18. D. Ramsuran, R. Bhimma, P. K. Ramdial et al., "The spectrum of HIV-related nephropathy in children," Pediatric Nephrology, vol. 27, no. 5, pp. 821-827, 2012.
19. I. C. Anochie, F. U. Eke, A. N. Okpere, "Human immunodeficiency virus-associated nephropathy (HIVAN) inNigerian children," Pediatric Nephrology, vol. 23, no. 1, pp. 117-122, 2008.
20. G. Genovese, D. J. Friedman, M. D. Ross et al., "Association of trypanolytic ApoL1 variants with kidney disease in African Americans," Science, vol. 329, no. 5993, pp. 841-845, 2010.
21. R. Bhimma, M. U. Purswani, U. Kala, "Kidney disease in children and adolescents with perinatal HIV-1 infection," Journal of the International AIDS Society, vol. 16, Article ID 18596, 2013.
22. M. Husain, V. D. D'Agati, J. C. He, M. E. Klotman, P. E. Klotman, "HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature ofHIVAN," AIDS, vol. 19,no. 17, pp. 1975-1980, 2005.
23. M. H. Gardenswartz, C. W. Lerner, G. R. Seligson et al., "Renal disease in patientswithAIDS: a clinicopathologic study," Clinical Nephrology, vol. 21, no. 4, pp. 197-204, 1984.
24. J. Soriano-Rosas, M. C. Avila-Casado, E. Carrera-Gonzalez, L. Chavez-Mercado, H. Cruz-Ortiz, J. Rojo, "AIDS-associated nephropathy: 5-year retrospective morphologic analysis of 87 cases," Pathology Research and Practice, vol. 194, no. 8, pp. 567-570, 1998.
25. C. Avila-Casado, T. I. Fortoul, S. S. Chugh, "HIV-associated nephropathy: experimental models," Contributions to Nephrology, vol. 169, pp. 270-285, 2011.
26. L. A. Bruggeman, M. D. Ross, N. Tanji et al., "Renal epithelium is a previously unrecognized site of HIV-1 infection," Journal of the American Society ofNephrology, vol. 11, no. 11, pp. 2079-2087, 2000.
27. J. Straus, C. Abitbol, G. Zilleruelo et al., "Renal disease in children with the acquired immunodeficiency syndrome," The New England Journal of Medicine, vol. 321, no. 10, pp. 625-630, 1989.
28. T. K. Chen, M. M. Estrella, R. S. Parekh, "The evolving science of apolipoprotein-L1 and kidney disease," Current Opinion inNephrology andHypertension, vol. 25,no. 3, pp. 217-225, 2016.
29. S. Limou, P. D. Dummer, G. W. Nelson, J. B. Kopp, C. A. Winkler, "APOL1 toxin, innate immunity, kidney injury," Kidney International, vol. 88, no. 1, pp. 28-34, 2015.
30. X. Lan, A. Jhaveri, K. Cheng et al., "APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability," American Journal of Physiology-Renal Physiology, vol. 307, no. 3, pp. F326-F336, 2014.
31. D. J. Friedman andM. R. Pollak, "Apolipoprotein L1 and kidney disease in African Americans," Trends in Endocrinology & Metabolism, vol. 27, no. 4, pp. 204-215, 2016.
32. B. T. Lee, V. Kumar, T. A. Williams et al., "The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival," American Journal of Transplantation, vol. 12, no. 7, pp. 1924-1928, 2012.
33. A. M. Reeves-Daniel, J. A. DePalma, A. J. Bleyer et al., "The APOL1 gene and allograft survival after kidney transplantation," American Journal of Transplantation, vol. 11, no. 5, pp. 1025-1030, 2011.
34. P. E. Ray and C.-A. A. Hu, "Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children," Future Virology, vol. 6, no. 7, pp. 883-894, 2011.
35. X. Lan, H. Wen, M. A. Saleem et al., "Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu," Experimental and Molecular Pathology, vol. 98, no. 3, pp. 491-501, 2015.
36. L. A. Bruggeman, Z. Wu, L. Luo et al., "APOL1-G0 or APOL1-G2 transgenic models develop preeclampsia but not kidney disease," Journal of the American Society of Nephrology, 2016.
37. P. E. Ray, "Taking a hard look at the pathogenesis of childhood HIV-associated nephropathy," Pediatric Nephrology, vol. 24, no. 11, pp. 2109-2119, 2009.
38. M. I. McCulloch and P. E. Ray, "Kidney disease in HIV-positive children," Seminars in Nephrology, vol. 28, no. 6, pp. 585-594, 2008.
39. P. L. Kimmel, L. Barisoni, J. B. Kopp, "Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, genetic investigations," Annals of InternalMedicine, vol. 139, no. 3, pp. 214-226, 2003.
40. WHO, Antiretroviral therapy of HIV infection in infants and children: towards univesal access, 2006, http://www. who. int/hiv/pub/guidelines/art/en/print. html.
41. L. A. Szczech, S. K. Gupta, R. Habash et al., "The clinical epidemiology and course of the spectrum of renal diseases associated withHIVinfection," Kidney International, vol. 66,no. 3, pp. 1145-1152, 2004.
42. M. J. Ross and P. E. Klotman, "Recent progress in HIVassociated nephropathy," Journal of the American Society of Nephrology, vol. 13, no. 12, pp. 2997-3004, 2002.
43. T. S. Ahuja, K. C. Abbott, L. Pack, Y.-F. Kuo, "HIV-associated nephropathy and end-stage renal disease in children in the United States," Pediatric Nephrology, vol. 19, no. 7, pp. 808-811, 2004.
44. United States Department of Health and Human Services, Guide for HIV/AIDS ClinicalCare, 2014, https://aidsinfo. nih. gov/guidelines/html/2/pediatric-treatment-guidelines/0.
45. WHO, Guidance on Prevention ofViralHepatitis B and C Among PeopleWho Inject Drugs, 2012.
46. B. J. McMahon, W. L. M. Alward, D. B. Hall et al., "Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state,"The Journal of Infectious Diseases, vol. 151, no. 4, pp. 599-603, 1985.
47. C. Y. Lin, "Clinical features and natural course of HBV-related glomerulopathy in children," Kidney International Supplement, vol. 35, pp. S46-S53, 1991.
48. K. Sakai, N. Morito, J. Usui et al., "Focal segmental glomerulosclerosis as a complication of hepatitis B virus infection," Nephrology Dialysis Transplantation, vol. 26, no. 1, pp. 371-373, 2011.
49. A. Khaira, B. K. Upadhyay, A. Sharma et al., "Hepatitis B virus associated focal and segmental glomerular sclerosis: report of two cases and review of literature," Clinical and Experimental Nephrology, vol. 13, no. 4, pp. 373-377, 2009.
50. S. O. Ozdamar, S. Gucer, K. Tinaztepe, "Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children," Pediatric Nephrology, vol. 18, no. 1, pp. 23-28, 2003.
51. K. N. Lai, J. S. Tam, H. J. Lin, F. M.-M. Lai, "The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia," Nephron, vol. 54, no. 1, pp. 12-17, 1990.
52. H. Taskapan, O. Oymak, A. Dogukan, O. Ozbakir, C. Utas, "Transformation of hepatitis B virus-relatedmembranous glomerulonephritis to crescentic form," Clinical Nephrology, vol. 54, no. 2, pp. 161-163, 2000.
53. F. L. Connor, A. R. Rosenberg, S. E. Kennedy,T. D. Bohane, "HBV associated nephrotic syndrome: resolution with oral lamivudine," Archives of Disease in Childhood, vol. 88, no. 5, pp. 446-449, 2003.
54. O. Sakallioglu, F. Gok, S. Kalman,A. E. Kurekci,O. Gunhan, E. Gokcay, "Hepatitis B complicated focal segmental glomerulosclerosis," Journal of Nephrology, vol. 18, no. 4, pp. 433-435, 2005.
55. C. Reinheimer, R. Allwinn, H. W. Doerr, M. Wittek, "Seroepidemiology of parvovirus B19 in the Frankfurt amMain area, Germany: evaluation of risk factors," Infection, vol. 38, no. 5, pp. 381-385, 2010.
56. K. J. Wierenga, J. R. Pattison,N. Brink et al., "Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease," The Lancet, vol. 346, no. 8973, pp. 475-476, 1995.
57. T. Y. H. Wong, P. K. S. Chan, C. B. Leung, C.-C. Szeto, J. S. Tam, P. K. T. Li, "Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus," American Journal of Kidney Diseases, vol. 34, no. 6, pp. 1132-1136, 1999.
58. W. C. Koch, J. H. Harger,B. Barnstein, S. P. Adler, "Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy," The Pediatric Infectious Disease Journal, vol. 17, no. 6, pp. 489-494, 1998.
59. M. Enders, A. Weidner, I. Zoellner, K. Searle, G. Enders, "Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases," Prenatal Diagnosis, vol. 24, no. 7, pp. 513-518, 2004.
60. A. Moudgil, C. C. Nast, A. Bagga et al., "Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy," Kidney International, vol. 59,no. 6, pp. 2126-2133, 2001.
61. P. Onguru, F. Dede, H. Bodur et al., "Glomerulonephritis associating parvovirus B19 infection," Renal Failure, vol. 28, no. 1, pp. 85-88, 2006.
62. S. M. Meehan, M. Pascual, W. W. Williams et al., "De novo collapsing glomerulopathy in renal allografts," Transplantation, vol. 65, no. 9, pp. 1192-1197, 1998.
63. C. Ponticelli, G. Moroni, R. J. Glassock, "De novo glomerular diseases after renal transplantation," Clinical Journal of the American Society ofNephrology, vol. 9, no. 8,pp. 1479-1487, 2014.
64. S. Tanawattanacharoen, R. J. Falk, J. C. Jennette, J. B. Kopp, "Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis," American Journal of Kidney Diseases, vol. 35, no. 6, pp. 1166-1174, 2000.
65. T. Nakazawa, N. Tomosugi, K. Sakamoto et al., "Acute glomerulonephritis after human parvovirus B19 infection," American Journal of Kidney Diseases, vol. 35, article E31, 2000.
66. L. Barisoni, W. Kriz, P. Mundel, V. D'Agati, "The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy," Journal of the American Society of Nephrology, vol. 10, no. 1, pp. 51-61, 1999.
67. K. E. Brown, S. M.,erson, N. S. Young, "Erythrocyte P antigen: cellular receptor for B19 parvovirus," Science, vol. 262, no. 5130, pp. 114-117, 1993.
68. L. L. W. Cooling, T. A. W. Koerner, S. J. Naides, "Multiple glycosphingolipids determine the tissue tropism of parvovirus B19," Journal of Infectious Diseases, vol. 172, no. 5, pp. 1198-1205, 1995.
69. A. K. Dettmar, E. Binder, F. R. Greiner et al., "Protection of human podocytes from shiga toxin 2-induced phosphorylation of mitogen-activated protein kinases and apoptosis by human serum amyloid P component," Infection and Immunity, vol. 82, no. 5, pp. 1872-1879, 2014.
70. A. P. Sanchez and D. M. Ward, "Therapeutic apheresis for renal disorders," Seminars in Dialysis, vol. 25, no. 2, pp. 119-131, 2012.
71. M. Albaqumi, T. J. Soos, L. Barisoni, P. J. Nelson, "Collapsing glomerulopathy," Journal of the American Society of Nephrology, vol. 17, no. 10, pp. 2854-2863, 2006.
72. H. Kaito, K. Kamei, E. Kikuchi et al., "Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin," Pediatric Nephrology, vol. 25, no. 5, pp. 957-959, 2010.
73. J. K. Tucker, "Focal segmental glomerulosclerosis in African Americans," The American Journal of the Medical Sciences, vol. 323, no. 2, pp. 90-93, 2002.
74. G. Crenshaw, S. Bigler, M. Salem, E. D. Crook, "Focal segmental glomerulosclerosis in African Americans: effects of steroids and angiotensin converting enzyme inhibitors," The AmericanJournal of theMedical Sciences, vol. 319, no. 5,pp. 320-325, 2000.
75. S. A. S. Staras, W. D. Flanders, S. C. Dollard, R. F. Pass, J. E. McGowan Jr.,M. J. Cannon, "Cytomegalovirus seroprevalence and childhood sources of infection: a population-based study among pre-adolescents in the United States," Journal of Clinical Virology, vol. 43, no. 3, pp. 266-271, 2008.
76. S. L. Bate, S. C. Dollard, M. J. Cannon, "Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004," Clinical Infectious Diseases, vol. 50, no. 11, pp. 1439-1447, 2010.
77. Z. W. Naing, G. M. Scott, A. Shand et al., "Congenital cytomegalovirus infection in pregnancy: a reviewof prevalence, clinical features, diagnosis and prevention," The Australian & New Zealand Journal of Obstetrics & Gynaecology, vol. 56, no. 1, pp. 9-18, 2016.
78. A. L. Distéfano, A. Alonso, F. Martin, F. Pardon, "Human cytomegalovirus: detection of congenital and perinatal infection in Argentina," BMC Pediatrics, vol. 4, article 11, 2004.
79. S. B. Boppana, S. A. Ross, K. B. Fowler, "Congenital cytomegalovirus infection: clinical outcome," Clinical Infectious Diseases, vol. 57, pp. S178-S181, 2013.
80. M. Bromfield, R. McQuillan, R. John, C. Avila-Casado, "The significance of tubuloreticular inclusions as a marker of systemic stimulation by interferons in a case of focal and segmental glomerulosclerosis associated with cytomegalovirus (CMV) infection," Clinical Kidney Journal, vol. 7, no. 2, pp. 174-178, 2014.
81. C. La Rosa andD. J. Diamond, "Theimmune response to human CMV," Future Virology, vol. 7, no. 3, pp. 279-293, 2012.
82. C. Presne, C. Cordonnier, R. Makdassi, A. Pruna, A. Fournier, "Collapsing glomerulopathy and cytomegalovirus, what are the links" Presse Medicale, vol. 29, no. 33, pp. 1815-1817, 2000.
83. L. Tomlinson, Y. Boriskin, I. McPhee, S. Holwill, P. Rice, "Acute cytomegalovirus infection complicated by collapsing glomerulopathy," Nephrology Dialysis Transplantation, vol. 18, no. 1, pp. 187-189, 2003.
84. H. F. Wechsler, A. H. Rosenblum, C. T. Sills, "Infectious mononucleosis; report of an epidemic in an Army post," Annals of Internal Medicine, vol. 25, p. 113, 1946.
85. S. Lee and C. M. Kjellstrand, "Renal disease in infectious mononucleosis," Clinical Nephrology, vol. 9, no. 6, pp. 236-240, 1978.
86. J. L. Becker, F. Miller,G. J. Nuovo, C. Josepovitz,W. H. Schubach, E. P. Nord, "Epstein-Barr virus infection of renal proximal tubule cells: possible role in chronic interstitial nephritis," The Journal of Clinical Investigation, vol. 104, no. 12, pp. 1673-1681, 1999.
87. J. M. Frazao, L. Elangovan, A. J. Felsenfeld, T. M. Stanley, A. H. Cohen, "Epstein-Barr-virus-induced interstitial nephritis in an HIV-positive patient with progressive renal failure," Nephrology, Dialysis, Transplantation, vol. 13, pp. 1849-1852, 1998.
88. M. Kunimoto, Y. Hayashi, K. Kuki et al., "Analysis of viral infection in patients with iga nephropathy," Acta Oto-Laryngologica, vol. 113, supplement 508, pp. 11-18, 1993.
89. R. Ranganath, A. R. Pandey, M. Pavan, "Crescentic glomerulonephritis and leucocytoclastic vasculitis associated with acute EBV infection," Nephrology, vol. 16, no. 6, p. 617, 2011.
90. C. E. Araya, R. P. González-Peralta, S. Skoda-Smith, V. R. Dharnidharka, "Systemic Epstein-Barr virus infection associated with membranous nephropathy in children," Clinical Nephrology, vol. 65, no. 3, pp. 160-164, 2006.
91. A. Joshi, A. Arora, D. Cimbaluk, G. Dunea, P. Hart, "Acute Epstein-Barr virus infection-associated collapsing glomerulopathy," Clinical Kidney Journal, vol. 5, no. 4, pp. 320-322, 2012.